BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7920935)

  • 1. [Estrogen-progestin contraception. Disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex; 1993 Jun; 21(6):481-8. PubMed ID: 7920935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estrogen-progestin contraception. Advantages of estrogen reduction].
    Cohen J
    Contracept Fertil Sex; 1993 Jun; 21(6):489-94. PubMed ID: 7920936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pros and cons of triphasic oral contraception].
    Berdah J
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral contraception: advantages of estrogen reduction].
    Cohen J
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):489-94. PubMed ID: 12318239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How to choose an oral contraceptive in 1984].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian and endometrial function during hormonal contraception.
    ESHRE Capri Workshop Group
    Hum Reprod; 2001 Jul; 16(7):1527-35. PubMed ID: 11425842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral contraception].
    Prolongeau JF
    Soins Gynecol Obstet Pueric Pediatr; 1993 Feb; (141):24-30. PubMed ID: 8278887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follicular ovarian cysts appearing during progestin or estroprogestin oral contraception at low doses].
    Netter A; Gabriel R
    Bull Acad Natl Med; 1988 May; 172(5):711-5. PubMed ID: 3056584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of biphasic and triphasic pills.
    Cohen J
    IPPF Med Bull; 1985 Aug; 19(4):1-2. PubMed ID: 12280230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk.
    Lurie G; Thompson P; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Obstet Gynecol; 2007 Mar; 109(3):597-607. PubMed ID: 17329510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.